Coya Therapeutics, Inc. (COYA)
4.81
-0.03
(-0.62%)
USD |
NASDAQ |
May 22, 16:00
4.79
-0.02
(-0.42%)
After-Hours: 20:00
Coya Therapeutics EPS Diluted (Quarterly) : -0.3183 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NanoViricides, Inc. | -0.0921 |
| Pyxis Oncology, Inc. | -0.3667 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.207M |
| Revenue (Quarterly) | 0.2511M |
| Total Expenses (Quarterly) | 7.458M |
| Enterprise Value | 62.10M |
| Gross Profit Margin (Quarterly) | 98.88% |
| Profit Margin (Quarterly) | -2.87K% |
| Earnings Yield | -22.49% |
| Normalized Earnings Yield | -20.80 |